Κimon Stamatelopoulos

6.5k total citations · 1 hit paper
166 papers, 4.2k citations indexed

About

Κimon Stamatelopoulos is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Κimon Stamatelopoulos has authored 166 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Cardiology and Cardiovascular Medicine, 36 papers in Molecular Biology and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Κimon Stamatelopoulos's work include Cardiovascular Health and Disease Prevention (61 papers), Blood Pressure and Hypertension Studies (28 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Κimon Stamatelopoulos is often cited by papers focused on Cardiovascular Health and Disease Prevention (61 papers), Blood Pressure and Hypertension Studies (28 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Κimon Stamatelopoulos collaborates with scholars based in Greece, United Kingdom and Germany. Κimon Stamatelopoulos's co-authors include Konstantinos Stellos, Christos Papamichael, Georgios Georgiopoulos, John Lekakis, Marco Sachse, Meletios Α. Dimopoulos, Constantinos Bakogiannis, Ignatios Ikonomidis, Ιrene Lambrinoudaki and Ageliki Laina and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Κimon Stamatelopoulos

163 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

2021 182 citations Κimon Stamatelopoulos, Evmorfia Aivalioti et al. profile →

Peers

Countries citing papers authored by Κimon Stamatelopoulos

Since Specialization

Citations

This map shows the geographic impact of Κimon Stamatelopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Κimon Stamatelopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Κimon Stamatelopoulos more than expected).

Fields of papers citing papers by Κimon Stamatelopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Κimon Stamatelopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Κimon Stamatelopoulos. The network helps show where Κimon Stamatelopoulos may publish in the future.

Co-authorship network of co-authors of Κimon Stamatelopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Κimon Stamatelopoulos. A scholar is included among the top collaborators of Κimon Stamatelopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Κimon Stamatelopoulos. Κimon Stamatelopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating amyloid beta 1‐40 peptide as an associate of renal function decline 2025 ·European Journal of Clinical Investigation ·(unknown), Georgios Georgiopoulos, Georgios Zervas, Evmorfia Aivalioti, Dimitrios Delialis, Ioannis N. Petropoulos, (unknown), (unknown), (unknown), Maria Dimopoulou, Marco Sachse, Simon Tual‐Chalot, Kateryna Sopova, (unknown), Konstantinos Stellos, Κimon Stamatelopoulos	1
2	Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride‐glucose index 2025 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), (unknown), Dimitrios Terentes‐Printzios, Georgios Zervas, (unknown), (unknown), (unknown), (unknown), Christina Chrysochoou, Konstantinos Tsioufis, (unknown), Evangelos Liberopoulos, Konstantinos Stellos, Charalambos Vlachopoulos, Demosthenes B. Panagiotakos, Κimon Stamatelopoulos	0
3	Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study 2024 ·European Journal of Clinical Investigation ·(unknown), Georgios Georgiopoulos, Dimitrios Delialis, (unknown), (unknown), Eleni Maneta, (unknown), Εvangelos Εvangelou, Κimon Stamatelopoulos	2
4	Amyloid-beta metabolism in age-related neurocardiovascular diseases 2024 ·European Heart Journal ·Evmorfia Aivalioti, Georgios Georgiopoulos, Simon Tual‐Chalot, Dimitrios Bampatsias, (unknown), Kateryna Sopova, Stavros G. Drakos, Konstantinos Stellos, Κimon Stamatelopoulos	6
5	SARS-CoV-2 infection-related deregulation of blood lipids in a patient with -/-LDLR familial homozygous hypercholesterolemia: A case report 2023 ·Journal of clinical lipidology ·Dimitrios Bampatsias, (unknown), Dimitrios S. Karagiannakis, (unknown), Eleni Korompoki, (unknown), Erasmia Psimenou, Georgia Trakada, George Papatheodoridis, Κimon Stamatelopoulos	1
6	Implementation of risk enhancers in ASCVD risk estimation and hypolipidemic treatment eligibility: A sex-specific analysis 2023 ·Hellenic Journal of Cardiology ·Georgios Georgiopoulos, Dimitrios Delialis, Evmorfia Aivalioti, (unknown), (unknown), (unknown), Dimitrios Bampatsias, Eleni Armeni, Eleni Maneta, (unknown), (unknown), (unknown), John Kanakakis, Ιrene Lambrinoudaki, Areti Lagiou, (unknown), Κimon Stamatelopoulos	1
7	Current Toolset in Predicting Acute Coronary Thrombotic Events: The “Vulnerable Plaque” in a “Vulnerable Patient” Concept 2023 ·Life ·(unknown), (unknown), Héctor M. García‐García, Κimon Stamatelopoulos, John Kanakakis, Michail I. Papafaklis	2
8	Transthyretin amyloidosis cardiomyopathy in Greece: Clinical insights from the National Referral Center 2023 ·Hellenic Journal of Cardiology ·(unknown), Foteini Theodorakakou, Αlexandros Briasoulis, Georgios Georgiopoulos, (unknown), (unknown), Ioannis Papantoniou, (unknown), (unknown), (unknown), (unknown), Dimitrios Delialis, Alexandra Papathoma, Georgios Koutsis, (unknown), Κimon Stamatelopoulos, Efstathios Kastritis	8
9	Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe 2022 ·European Respiratory Review ·Constantine Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, Κimon Stamatelopoulos, Georgios Georgiopoulos, Revati Phalkey, Jo Leonardi‐Bee, Esteve Fernández, Dolors Carnicer-Pont, Jørgen Vestbo, Jan C. Semenza, Charlotte Deogan, Jonathan E. Suk, Piotr Kramarz, Favelle Lamb, Pasi Penttinen	55
10	Endothelial Function in Postmenopausal Women: The Possible Role of Heat Shock Protein 60 and Serum Androgens 2022 ·PubMed ·Eleni Armeni, (unknown), Areti Augoulea, (unknown), (unknown), George Kaparos, Dimitrios Delialis, (unknown), (unknown), (unknown), (unknown), Andreas Alexandrou, Stavroula Baka, Leon Aravantinos, Konstantinos Panoulis, Κimon Stamatelopoulos, Ιrene Lambrinoudaki	3
11	UTILIZATION AND TOLERANCE OF BETA-BLOCKERS AMONG PATIENTS WITH AL AMYLOIDOSIS 2021 ·Journal of the American College of Cardiology ·Αlexandros Briasoulis, Κimon Stamatelopoulos, (unknown), (unknown), Maria Gavriatopoulou, Meletios Α. Dimopoulos, Efstathios Kastritis	0
12	Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system 2020 ·Cardiovascular Research ·Luca Liberale, Alexander Akhmedov, Nikolaos I. Vlachogiannis, Nicole R. Bonetti, Vanasa Nageswaran, Melroy Miranda, Yustina M. Puspitasari, (unknown), Sarah Costantino, Francesco Paneni, Jürg H. Beer, Frank Ruschitzka, Fabrizio Montecucco, Thomas F. Lüscher, Κimon Stamatelopoulos, Konstantinos Stellos, Giovanni G. Camici	23
13	Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry 2019 ·Journal of Stroke and Cerebrovascular Diseases ·Georgios Georgiopoulos, George Ntaios, Κimon Stamatelopoulos, Efstathios Manios, Eleni Korompoki, Evangelia Vemmou, Haralampos Milionis, Stefano Masi, Gregory Y.H. Lip, Konstantinos Vemmos	6
14	The TyG Index as a Marker of Subclinical Atherosclerosis and Arterial Stiffness in Lean and Overweight Postmenopausal Women 2017 ·Heart Lung and Circulation ·Ιrene Lambrinoudaki, Maria Kazani, Eleni Armeni, Georgios Georgiopoulos, (unknown), Demetrios Rizos, Areti Augoulea, Georgios Kaparos, Andreas Alexandrou, Κimon Stamatelopoulos	94
15	Circulating levels of TNF-like cytokine 1A correlate with reflected waves and atherosclerosis extent and may predict cardiac death in patients with stable coronary artery disease 2015 ·Cytokine ·Κimon Stamatelopoulos, (unknown), John Kanakakis, Christos Papamichael, (unknown), Aimilia Mantzou, Elisabeth C. Samouilidou, (unknown), Nikolaos Zakopoulos, Petros P. Sfikakis	7
16	Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype 2013 ·Journal of Hypertension ·Eleni Armeni, Κimon Stamatelopoulos, Demetrios Rizos, Georgios Georgiopoulos, Maria Kazani, (unknown), (unknown), Konstantinos Stellos, Konstantinos Panoulis, Andreas Alexandrou, Maria Creatsa, Christos Papamichael, Ιrene Lambrinoudaki	35
17	Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets 2012 ·Platelets ·Dimitrios Stakos, Aikaterini Gatsiou, Κimon Stamatelopoulos, Alexandros D. Tselepis, Konstantinos Stellos	25
18	Expression of platelet‐bound stromal cell‐derived factor‐1 in patients with non‐valvular atrial fibrillation and ischemic heart disease 2011 ·Journal of Thrombosis and Haemostasis ·Konstantinos Stellos, (unknown), (unknown), (unknown), Kateryna Sopova, Κimon Stamatelopoulos, (unknown), Slawomir Weretka, Tobias Geisler, Meinrad Gawaz, Hans‐Jörg Weig, Boris Bigalke	21
19	Reversal of increased arterial stiffness in severely depressed women after 6-week antidepressant treatment 2009 ·Journal of Affective Disorders ·Panagiotis Oulis, Anastasios V. Kouzoupis, Katerina Kyrkou, Vasilios G. Masdrakis, Georgios Georgiopoulos, (unknown), (unknown), Nicolas A. Karakatsanis, (unknown), George N. Papadimitriou, Christos Papamichael, Κimon Stamatelopoulos	23
20	Hour-to-hour and week-to-week variability and reproducibility of wave reflection indices derived by aortic pulse wave analysis: implications for studies with repeated measurements 2007 ·Journal of Hypertension ·Theodore G. Papaioannou, Emmanouil Karatzis, Kalliopi Karatzi, Elias Gialafos, Athanase D. Protogerou, Κimon Stamatelopoulos, Christos Papamichael, John Lekakis, Christodoulos Stefanadis	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact